Lung Therapeutics, Inc. Raises $36 Million in Series C Financing

Lung Therapeutics, Inc. Raises $36 Million in Series C Financing

HUGE congrats to member company, Lung Therapeutics, on their $36 Million Series C financing to advance their clinical pipeline. Lung Therapeutics has been a member of ACC Bioscience Incubator since January 2018 and we are so proud of their success. Read more via Yahoo...